Page last updated: 2024-10-28

hexamethonium and Brain Neoplasms

hexamethonium has been researched along with Brain Neoplasms in 2 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GUIDETTI, B1
ALVISI, C1
Nelson, ME1
Lindstrom, J1

Other Studies

2 other studies available for hexamethonium and Brain Neoplasms

ArticleYear
[Hexamethonium in neurosurgery and neurology].
    Rivista di patologia nervosa e mentale, 1954, Volume: 75, Issue:1

    Topics: Analgesia; Anesthesia; Anesthesia and Analgesia; Brain; Brain Neoplasms; Hexamethonium; Hypotension;

1954
Single channel properties of human alpha3 AChRs: impact of beta2, beta4 and alpha5 subunits.
    The Journal of physiology, 1999, May-01, Volume: 516 ( Pt 3)

    Topics: Animals; Brain Neoplasms; Electrophysiology; Hexamethonium; Humans; Kinetics; Mecamylamine; Neurobla

1999